Boston Scientific Announces Results For First Quarter 2017
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/7/2026
- S&P closes at record high as soft jobs report eases rate-hike concerns
- US suffers unexpected job losses in July, markets dial back rate hike expectations
- Brent climbs $1 on uncertainty over end to Iran war
- Atlassian results seen as 'game changer' for AI kills software worries
- The Trade Desk hit by Wall St downgrades after disappointing Q2 results, outlook
- Trump held multiple undisclosed calls with Fed Chair Warsh, reports say
- Citi says buy the pullback in memory stocks as upcycle is still in early innings
- Stocks close lower as investors eye Mideast talks, earnings
- The Trade Desk Inc. (TTD) Tops Q2 EPS by 16c, Misses on Revenue; Offers Weak Q3 Revenue Guidance
- Apollo to acquire easyJet for £5.7B in cash deal
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
- After-Hours Movers: SPCX, AMD, ANET, PINS, APPS, UPST, ZETA, BKNG, LCID, CPNG, MTCH
- After-Hours Stock Movers: PLTR, SNAP, ON, ICHR, WGS, WHR
- After-Hours Stock Movers: AAPL, AMZN, COIN, RBLX, RDDT, AXTI, FND, WU, GDDY
Boston Scientific (BSX) PT Raised to $30 at Needham & Company
April 27, 2017 3:58 PM EDTNeedham & Company raised its price target on Boston Scientific (NYSE: BSX) to $30.00 (from $29.00) while maintaining a Buy rating.
... MoreBoston Scientific (BSX) PT Raised to $30 at Stifel
April 27, 2017 3:55 PM EDTStifel raised its price target on Boston Scientific (NYSE: BSX) to $30.00 (from $28.00) while maintaining a Buy rating.
... MoreBoston Scientific (BSX) PT Raised to $31 at Cowen
April 27, 2017 1:03 PM EDTCowen raised its price target on Boston Scientific (NYSE: BSX) to $31.00 (from $29.00) while maintaining a Outperform rating amid "robust" top-line performance.
Analyst Joshua Jennings said the reason the company gave for the margin shortfall - non-recurring expenses- is "very plausible" and they... More
Boston Scientific (BSX) PT Raised to $28.50 at Evercore ISI; Revenue Beat was 'Remarkable'
April 27, 2017 12:00 PM EDTEvercore ISI raised its price target on Boston Scientific (NYSE: BSX) to $28.50 (from $26.50) while maintaining a Outperform rating after the company "curshed" it on revenues for the quarter.
Analyst Vijay Kumar, "In large cap land, organic revenue beats of >400 bps... More
